Recent findings have linked flotillin overexpression with various types of cancers, and our data show that flotillin-1 depletion in breast cancer cells may result in overexpression of the EGFR.53 Therefore, flotillins evidently regulate the proliferative signalling axis by several means, including receptor activation, degradation and downstream signalling. This evidence concerns the gene EGFR and breast carcinoma.